Liz Parrish is the Founder and CEO of BioViva Sciences USA Inc.
https://www.youtube.com/channel/UCaBq8hEExcUN6
You can support me:
PayPal: alexandrpadalka@gmail.com
Gpay: exhuman.machina@gmail.com
Patreon: https://www.patreon.com/user?u=27929324
Covid-19 hits the old hardest, but young people are dying too. Scientists say it may be down to genes or ‘viral load’.
Could used for anything to reduce size just like an ant man suit :3.
Scientists can put all kinds of useful materials in the polymer before they shrink it such as metals, quantum dots and DNA. Pictured is the machine used to shrink objects.
The polyacrylate forms the scaffold over which other materials can be attached.
Continue reading “Real life ‘shrink ray’ can reduce 3D structures” »
A drug used to treat HIV and cancer patients has shown success in treating some of the most severe coronavirus patients and was just cleared by the U.S. Food and Drug Administration to start a phase two clinical trial. Much of the work behind the drug is happening in Washington state.
Dr. Derek Yach, Founder, President, and Board Member of The Foundation for a Smoke-Free World (FSFW), joined me on ideaXme (http://radioideaxme.com/) to discuss his group’s work in the core areas of Agriculture and Livelihoods, Industry Transformation, and Health, Science, and Technology (Disclosure — FSFW is funded ~$US1 Billion by Philip Morris International, but take a listen to full story…) — #Ideaxme #Smoking #Vaping #Tobacco #Cessation #AlternativeUses #HarmReduction #WHO #CDC #Health #Wellness #Longevity #Biotechnology #LifeExtension #Aging #IraPastor #Bioquark #Regenerage World Health Organization (WHO) CDC CDC Global United Nations Philip Morris International.
Ira Pastor, ideaXme life sciences ambassador and founder of Bioquark, interviews Dr. Derek Yach, founder, president, and board member of The Foundation for a Smoke-Free World, and passionate advocate for health promotion and disease prevention. Dr Yach’s objective is to end smoking in this generation. We investigated to see how that might be achieved.
Research involving bowhead whales has suggested that it may one day be possible to extend the human lifespan to 200 years.
From the demigods of Greek mythology to the superheroes of 20th century comic books, we’ve been intrigued by the idea of human enhancement for quite a while, but we’ve also worried about negative consequences. Both in the Greek myths and modern comics and television, each enhanced human has been flawed in some way.
Continue reading “Creating Superman (and woman): Who benefits from human enhancement?” »
We have the technology to potentially add a 47th chromosome, to compound as it were, a new human entity. The implications are enormously consequential.
C.S. Lewis warned about our final mastery over nature, and the inevitable drift into a future world where knowledge about the old world completely vanishes, where what once was, irretrievably transforms into something else:
Researchers at University of Pittsburgh School of Medicine report the creation of a promising COVID-19 vaccine candidate – named PittCoVacc – and are hoping for a fast approval track, lasting less than the usual year of testing, by the U.S. Food and Drug Administration (FDA).
:oooo.
Precision oncology relies on accurate discovery and interpretation of genomic variants, enabling individualized diagnosis, prognosis and therapy selection. We found that six prominent somatic cancer variant knowledgebases were highly disparate in content, structure and supporting primary literature, impeding consensus when evaluating variants and their relevance in a clinical setting. We developed a framework for harmonizing variant interpretations to produce a meta-knowledgebase of 12,856 aggregate interpretations. We demonstrated large gains in overlap between resources across variants, diseases and drugs as a result of this harmonization. We subsequently demonstrated improved matching between a patient cohort and harmonized interpretations of potential clinical significance, observing an increase from an average of 33% per individual knowledgebase to 57% in aggregate. Our analyses illuminate the need for open, interoperable sharing of variant interpretation data. We also provide a freely available web interface (search.cancervariants.org) for exploring the harmonized interpretations from these six knowledgebases.
